Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

The Trump administration is systematically undermining women’s reproductive rights

Monica Agarwal, MD, Alexa Lindley, MD and Emily Godfrey, MD
Meds
September 14, 2020
305 Shares
Share
Tweet
Share

Just this week, the administration asked the U.S. Supreme Court to reverse a lower court ruling allowing women to receive telemedicine abortion services and pills delivered by mail during the COVID-19 pandemic. If Trump wins, millions of women across the U.S. risk losing this essential health care.

I met one such woman in my clinic a few months ago. She was a teenager, and she was tearfully anxious. She was seeking an abortion and had traveled over three hours from Eastern Washington to receive care in a Seattle clinic. She was unable to find a clinic closer to home that would offer her the treatment she was seeking.

With telemedicine and the recent ruling that allows women to receive abortion pills by mail, we can expand the reach of reproductive services into rural areas. My teenage patient would have been able to speak with a physician and obtain pills without the added burden of traveling long distances and potentially exposing herself to COVID-19.

In order to understand the current debate, it is important to know the history of abortion pill regulation.

Medication abortion is a common, safe, and effective way to end an early pregnancy. Approximately 340,000 pregnancies are ended with abortion pills in the United States each year. The regimen involves taking two pills: mifepristone followed by misoprostol a day later. These pills essentially induce a miscarriage, which occurs in the privacy of a person’s home.

The Food and Drug Administration (FDA) specifically targeted mifepristone after its approval in 2000 using the “Risk Evaluation and Mitigation Strategy” (REMS) that also governs certain drugs with safety concerns, like methadone, which is used to treat opiate addiction. These restrictions mandated that mifepristone be administered in clinics or hospitals, instead of picked up at retail pharmacies. They also mandated that physicians be certified by the drug company and attest to their qualifications.

To be fair, when mifepristone was first approved, we were still collecting data about its safety outside of a research context. We now have 20 years of data attest to its safety profile. In fact, the risk of death from pregnancy is about 14 times higher than the risk of death from an abortion in the first trimester.

Today, the REMS restrictions are just another onerous and unnecessary barrier to reproductive services. Clinics, unlike pharmacies, rarely function as dispensaries and maintaining drug supply is expensive. Other restrictions are simply redundant. For example, it is already standard of care for physicians to prove their qualifications with state licensing, multiple board examinations, and years of training.

The FDA loosened restrictions in 2016, allowing women to take mifepristone in their own homes after obtaining the pill in-person at a health care facility. Earlier this year, when the ACLU and American College of Obstetricians and Gynecologists filed suit, they claimed that the REMS “requirement imposes unnecessary COVID-19 risks and other burdens by forcing patients to travel to one of these clinical settings solely to pick up the medication and sign a form, even though, based on safety data, the FDA already permits patients to swallow the pill later at home.” Meanwhile, even opioids like methadone, which were previously administered in person, are now available for mail delivery or pharmacy pickup during the COVID-19 pandemic.

Pharmacists also agree. In the May 2018 Journal of the American Pharmacists Association, they concluded that “mifepristone no longer fits the profile of a drug that requires a REMS.” Meaning, if you can mail someone their methadone, you can certainly mail them mifepristone. By attempting to reverse the recent ruling in favor of mailed mifepristone, the Trump administration is undermining the expertise of our health professionals and scientists and attempting to chip away at our health care. Don’t let them.

Monica Agarwal, Alexa Lindley, and Emily Godfrey are family physicians. The opinions expressed in this op-ed are the personal views of the writers and do not represent the position of UW Medicine.

Image credit: Shutterstock.com

Prev

COVID-19 is rattling the nerves of preemie parents [PODCAST]

September 13, 2020 Kevin 0
…
Next

How primary care almost killed this physician

September 14, 2020 Kevin 9
…

Post navigation

< Previous Post
COVID-19 is rattling the nerves of preemie parents [PODCAST]
Next Post >
How primary care almost killed this physician

Related Posts

  • Shift from fighting for reproductive rights to fighting for reproductive justice

    Ira Memaj, MPH
  • Bias when treating supporters of President Trump

    Anonymous
  • Supporters of Obamacare should consider this Trump proposal

    Robert Laszewski
  • Do children need to exercise their Second Amendment rights?

    Jarret Patton, MD
  • Physicians have spoken. The Biden administration should listen.

    Ripley Hollister, MD
  • Got real rights? Not when seeking health care.              

    John T. James, PhD and Michael F. Mascia, MD, MPH

More in Meds

  • The deadly consequences of a shortage: The Pluvicto crisis leaves metastatic prostate cancer patients in limbo

    Matt Drewes
  • The real story of Xylazine contamination in street fentanyl and how we can manage it

    Julie Craig, MD
  • The cannabis education gap: Why patients are left in the dark

    Timothy Byars
  • Are doctors ready to discuss psychedelic therapies with patients?

    Thaís Salles Araujo, MD
  • The rise and dark side of fungi: Exploring health benefits and pathogenic threats

    Sandra Vamos, EdD and Deanna Lernihan, MPH
  • Advocacy and collaboration lead to major patient safety benefits on sterile pharmaceutical compounding: a review of USP’s revisions to Chapter <797>

    Elizabeth Rebello, MD
  • Most Popular

  • Past Week

    • A patient’s perspective on the diminishing relationship between doctors and patients

      Michele Luckenbaugh | Conditions
    • Unmasking wage disparity in health care: the truth behind the Elmhurst Hospital physician strike

      Kevin Pho, MD | KevinMD
    • Why affirmative action is crucial for health equity and social justice in medicine

      Katrina Gipson, MD, MPH | Policy
    • How electronic health records preserve patients’ legacies in the words of oncologists

      Marc Braunstein, MD, PhD | Physician
    • Unmasking the brutal reality of gun violence in America: a call to action for unity and meaningful change

      Osmund Agbo, MD | Policy
    • Emulating Michael Jordan’s winning mindset: a path to success for health care professionals and entrepreneurs

      Harvey Castro, MD, MBA | Physician
  • Past 6 Months

    • The growing threat to transgender health care: implications for patients, providers, and trainees

      Carson Hartlage | Policy
    • Breaking point: the 5 reasons American doctors are dreaming of walking away from medicine

      Amol Shrikhande, MD | Physician
    • “Is your surgeon really skilled? The hidden threat to public safety in medicine.

      Gene Uzawa Dorio, MD | Physician
    • It’s time to replace the 0 to 10 pain intensity scale with a better measure

      Mark Sullivan, MD and Jane Ballantyne, MD | Conditions
    • Breaking the cycle of racism in health care: a call for anti-racist action

      Tomi Mitchell, MD | Policy
    • Revolutionize your practice: the value-based care model that reduces physician burnout

      Chandravadan Patel, MD | Physician
  • Recent Posts

    • Why doctors aren’t to blame for the U.S. opioid crisis [PODCAST]

      The Podcast by KevinMD | Podcast
    • Raw humanity on night float: inspiring patient encounters and overcoming challenges

      Johnathan Yao, MD, MPH | Physician
    • Is AI the solution for the shortage of nephrologists? ChatGPT weighs in.

      Amol Shrikhande, MD | Tech
    • Unlocking the secrets of cancer conferences: an end-of-life counselor’s journey among pharmaceutical giants

      Althea Halchuck, EJD | Conditions
    • Why HIPAA is failing and what you need to know to protect your data [PODCAST]

      The Podcast by KevinMD | Podcast
    • Revolutionizing emergency medicine: Overcoming long-term challenges with innovative solutions for physicians and patients

      Anonymous | Physician

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 3 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

CME Spotlights

From MedPage Today

Latest News

  • What Drug Did FDA Just Approve for COVID?
  • PET Scan for Alzheimer's Dx; Predicting Colon Cancer Survival
  • What Happens When We Classify Kids' Weight as a 'Disease'?
  • Sotagliflozin Gets FDA's Blessing for Heart Failure
  • Cardiorespiratory Monitoring Can Be Telling of Outcomes in Extremely Preterm Infants

Meeting Coverage

  • No Access to Routine Healthcare Biggest Barrier to HPV Vaccination
  • Trial Results Spark Talk of Curing More Metastatic Cervical Cancers
  • Cross-Border Collaboration Improves Survival in Pediatric Leukemia Patients
  • Monoclonal Antibody Reduced Need For Transfusions in Low-Risk MDS
  • Less-Invasive Surgery for Pancreatic Cancer Proves Safe, Effective
  • Most Popular

  • Past Week

    • A patient’s perspective on the diminishing relationship between doctors and patients

      Michele Luckenbaugh | Conditions
    • Unmasking wage disparity in health care: the truth behind the Elmhurst Hospital physician strike

      Kevin Pho, MD | KevinMD
    • Why affirmative action is crucial for health equity and social justice in medicine

      Katrina Gipson, MD, MPH | Policy
    • How electronic health records preserve patients’ legacies in the words of oncologists

      Marc Braunstein, MD, PhD | Physician
    • Unmasking the brutal reality of gun violence in America: a call to action for unity and meaningful change

      Osmund Agbo, MD | Policy
    • Emulating Michael Jordan’s winning mindset: a path to success for health care professionals and entrepreneurs

      Harvey Castro, MD, MBA | Physician
  • Past 6 Months

    • The growing threat to transgender health care: implications for patients, providers, and trainees

      Carson Hartlage | Policy
    • Breaking point: the 5 reasons American doctors are dreaming of walking away from medicine

      Amol Shrikhande, MD | Physician
    • “Is your surgeon really skilled? The hidden threat to public safety in medicine.

      Gene Uzawa Dorio, MD | Physician
    • It’s time to replace the 0 to 10 pain intensity scale with a better measure

      Mark Sullivan, MD and Jane Ballantyne, MD | Conditions
    • Breaking the cycle of racism in health care: a call for anti-racist action

      Tomi Mitchell, MD | Policy
    • Revolutionize your practice: the value-based care model that reduces physician burnout

      Chandravadan Patel, MD | Physician
  • Recent Posts

    • Why doctors aren’t to blame for the U.S. opioid crisis [PODCAST]

      The Podcast by KevinMD | Podcast
    • Raw humanity on night float: inspiring patient encounters and overcoming challenges

      Johnathan Yao, MD, MPH | Physician
    • Is AI the solution for the shortage of nephrologists? ChatGPT weighs in.

      Amol Shrikhande, MD | Tech
    • Unlocking the secrets of cancer conferences: an end-of-life counselor’s journey among pharmaceutical giants

      Althea Halchuck, EJD | Conditions
    • Why HIPAA is failing and what you need to know to protect your data [PODCAST]

      The Podcast by KevinMD | Podcast
    • Revolutionizing emergency medicine: Overcoming long-term challenges with innovative solutions for physicians and patients

      Anonymous | Physician

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

The Trump administration is systematically undermining women’s reproductive rights
3 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...